New cholesterol-fighting drug slashes heart attack risk, but at a steep price; Amgen shares drop – CNBC


CNBC
New cholesterol-fighting drug slashes heart attack risk, but at a steep price; Amgen shares drop
CNBC
Amgen shares fell Friday after the company said its cholesterol-lowering drug failed to significantly lower mortality and costs more than many insurers want to pay. Called Repatha, the drug reduced the risk of heart attack, stroke or cardiovascular
Amgen cholesterol drug cuts heart attack, stroke risk but shares fallReuters
Amgen Tanks On Heart Study; Shares Of Other Drugmakers TumbleInvestor’s Business Daily

all 94 news articles >>

Source: shares – Google News

Sharing information is key – Share Dealing Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd